EAGLE PHARMACEUTICALS INC (EGRX)

US2697961082 - Common Stock

4.4  +0.21 (+5.01%)

After market: 4.4 0 (0%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2023-6-30)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
257.50M316.60M171.50M187.80M195.90M
Cost Of Goods
77.80M94.90M42.20M45.50M60.90M
Gross Profit
179.90M221.70M129.40M142.30M135.00M
Operating Expenses
137.30M119.40M126.60M109.30M113.20M
Research and Development
35.60M34.10M51.30M30.80M36.80M
Selling, General, and Administrative Expenses
102.10M85.20M75.30M78.60M76.40M
Operating Income
42.40M102.40M2.80M33.00M21.80M
Interest Income/Expense
-12.00M-12.90M-7.30M-2.00M-500.00K
Other Income/Expense
5.10M-1.70M0.00-8.30M700.00K
Non Recurring Items
N/A-26.40MN/A0.000.00
Income Before Taxes
29.10M61.40M-4.50M22.70M22.00M
Income Tax
17.20M25.80M4.10M10.70M7.70M
Net Income
12.10M35.60M-8.60M12.00M14.30M
EBITDA
63.02M114.43M6.56M36.54M26.45M
 
Per Share Data
EPS Diluted Total Ops
0.912.73-0.660.871.01
Non GAAP EPS
4.667.822.583.542.59
 
Statistics
Gross Profit Margin
69.86%70.03%75.45%75.77%68.91%
Profit Margin
4.70%11.24%-5.01%6.39%7.30%
Operating Profit Margin
16.47%32.34%1.63%17.57%11.13%

All data in USD

Charts